These alternative methods allow a minimally invasive and real‐time detection for a more accurate representation of the heterogenous expression of PD‐L1, and are feasible for dynamic monitoring of PD‐L1 status during anti‐cancer treatment.9 This evidence concerns the gene CD274 and cancer.